About University Medical Center Hamburg-Eppendorf
Das Universitätsklinikum Hamburg-Eppendorf, bis 2001 Universitätskrankenhaus Eppendorf, ist ein Krankenhaus der Universität Hamburg im Hamburger Stadtteil Eppendorf.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Universitätsklinikum Hamburg-Eppendorf
87
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
Allievex Corporation
3
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
3
Dutch Childhood Oncology Group
2
European Organisation for Research and Treatment of Cancer - EORTC
2
Intercept Pharmaceuticals
2
Ipsen
2
LYSOGENE
2
NovoCure Ltd.
2
Rigshospitalet, Denmark
2
Clinical Trials at University Medical Center Hamburg-Eppendorf
During the past decade, University Medical Center Hamburg-Eppendorf conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 8 clinical trials were completed, i.e. on
average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 4 clinical trials were completed. i.e. 10.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
1999-05-01
2009-12-01
Completed
350
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
2000-06-01
Unknown status
241
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
2005-02-01
Completed
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Medical Center Hamburg-Eppendorf" #1 sponsor was "Universitätsklinikum Hamburg-Eppendorf" with 87 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials
sponsored, "Allievex Corporation" with 3 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials sponsored and "Dutch Childhood Oncology Group"
with 3 trials sponsored. Other sponsors include 55 different institutions and
companies that sponsored additional 59 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center Hamburg-Eppendorf"
#1 collaborator was "Universitätsklinikum Hamburg-Eppendorf" with 5 trials as a collaborator, "Clinical Trial Center North (CTC North GmbH & Co. KG)" with 3 trials as a collaborator, "German Federal Ministry of Education and Research" with 3 trials as a collaborator, "Philipps University Marburg Medical Center" with 3 trials as a collaborator and "University of Rostock" with 3 trials as a collaborator. Other collaborators include 141 different institutions and companies that were
collaborators in the rest 143 trials.
Clinical Trials Conditions at University Medical Center Hamburg-Eppendorf
According to Clinical.Site data, the most researched conditions in "University Medical Center Hamburg-Eppendorf" are
"Leukemia" (7 trials), "Lymphoma" (6 trials), "Depression" (4 trials), "Neuroblastoma" (4 trials) and "Stroke" (4 trials). Many other conditions were trialed in "University Medical Center Hamburg-Eppendorf" in a lesser frequency.
Clinical Trials Intervention Types at University Medical Center Hamburg-Eppendorf
Most popular intervention types in "University Medical Center Hamburg-Eppendorf" are "Drug" (57 trials), "Procedure" (28 trials), "Other" (24 trials), "Biological" (20 trials) and "Behavioral" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "vincristine sulfate" (10 trials), "cyclophosphamide" (9 trials), "radiation therapy" (8 trials) and "doxorubicin hydrochloride" (7 trials). Other intervention names were less common.
Clinical Trials Genders at University Medical Center Hamburg-Eppendorf
The vast majority of trials in "University Medical Center Hamburg-Eppendorf" are
150 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at University Medical Center Hamburg-Eppendorf
Currently, there are 51 active trials in "University Medical Center Hamburg-Eppendorf".
2 are not yet recruiting,
30 are recruiting,
17 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 81 completed trials in University Medical Center Hamburg-Eppendorf,
1 suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in University Medical Center Hamburg-Eppendorf, 7 "Phase 1"
clinical trials were conducted, 35 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 48 trials that are defined as “Not Applicable".